//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileHeaderAlt
by @jakesimonds.com
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
ProfileWisp
by @cosmeffect.com
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Health economics, law, global health, and access to medicines. Economist @ MSF-USA but views my own. https://melissajbarber.github.io.
Melissa Barber
Loading...
I've walked thru the economic logic here, but Gilead obviously does not say this out loud. They don't really have a good reason not to sell to MSF, which is why they landed on negotiating supply contracts is "a lot of work" (actual thing they said). 13/ www.doctorswithoutborders.org/latest/preve...
14h
Melissa Barber
Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization.. statnews.com/pharmalot/20... #pharma #HIV #AIDS #pharma #Gilead
MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far short of the needs.
Open letter to Gilead: Prevention should not be a privilege
www.doctorswithoutborders.org
9h
The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir.
Doctors Without Borders calls Gilead 'unconscionable' for refusing to sell HIV prevention drug to organization
statnews.com